Long-term direct oral anticoagulation in primary osteonecrosis with elevated plasminogen activation inhibitor
Osteonecrosis is a pathological condition that could lead to a debilitating physical disease and impede daily activities. It is generally categorised into aetiology – primary (idiopathic) or secondary. When direct damage to the bone vasculature or direct injury of the bone marrow is related to an id...
Main Authors: | Maria Monica Haydock, Shahed Elhamdani, Mohamed Alsharedi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-02-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X19827747 |
Similar Items
-
Long Term Anticoagulation (4–16 Years) Stops Progression of Idiopathic Hip Osteonecrosis Associated with Familial Thrombophilia
by: Charles J. Glueck, et al.
Published: (2015-01-01) -
Reconsideration of Interactions Between Direct Oral Anticoagulants and Calcineurin Inhibitors
by: Zohre Labbani-Motlagh, et al.
Published: (2020-06-01) -
Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor‐1 and osteonecrosis risk in childhood acute lymphoblastic leukemia
by: Laila M. Sherief, et al.
Published: (2021-07-01) -
DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01) -
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
by: Toth PP
Published: (2016-02-01)